Issei Imoto Selected Research

Due To Mecp2 Mutations Neonatal Severe Encephalopathy

1/2018

A rare male patient with classic Rett syndrome caused by MeCP2_e1 mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Issei Imoto Research Topics

Disease

55	Neoplasms (Cancer) 10/2023 - 01/2002
15	Carcinogenesis 01/2020 - 12/2005
10	Stomach Neoplasms (Stomach Cancer) 01/2020 - 02/2005
7	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2002
7	Schizophrenia (Dementia Praecox) 02/2018 - 06/2013
7	Squamous Cell Carcinoma of Head and Neck 02/2016 - 06/2005
5	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 09/2005
5	Esophageal Squamous Cell Carcinoma 11/2017 - 01/2002
5	Intellectual Disability (Idiocy) 12/2014 - 09/2002
4	Carcinoma (Carcinomatosis) 04/2017 - 07/2007
4	Neuroblastoma 12/2011 - 04/2003
3	Breast Neoplasms (Breast Cancer) 07/2021 - 07/2015
3	Inflammation (Inflammations) 01/2019 - 01/2016
3	Adenocarcinoma of Lung 01/2019 - 09/2005
3	Hepatocellular Carcinoma (Hepatoma) 07/2012 - 12/2009
3	Lung Neoplasms (Lung Cancer) 12/2010 - 10/2003
3	Lymphatic Metastasis 07/2009 - 06/2005
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2006 - 12/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2005 - 09/2003
2	Insulin Resistance 01/2023 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 07/2015
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 10/2018
2	Atherosclerosis 01/2019 - 10/2018
2	Basal Cell Nevus Syndrome (Gorlin Syndrome) 06/2017 - 01/2015
2	Leukemia 01/2013 - 01/2006
2	Clear Cell Adenocarcinoma 06/2012 - 04/2009
2	Spontaneous Remission 12/2011 - 09/2009
2	Mouth Neoplasms (Oral Cancer) 09/2011 - 04/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2010 - 07/2007
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 09/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2007 - 04/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Multiple pterygium syndrome 01/2023
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2023
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2023
1	Pterygium 01/2023
1	Epilepsy (Aura) 11/2021
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2021
1	Necrosis 01/2021
1	Wilms Tumor (Wilm's Tumor) 01/2020
1	Mesothelioma 01/2020
1	Ascites 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

28	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2002
18	Proteins (Proteins, Gene)FDA Link 11/2017 - 09/2003
7	A-factor (Streptomyces)IBA 01/2020 - 12/2005
6	MicroRNAs (MicroRNA)IBA 11/2017 - 04/2008
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2010
5	Phosphotransferases (Kinase)IBA 01/2014 - 12/2006
4	LipidsIBA 12/2022 - 01/2018
4	RNA (Ribonucleic Acid)IBA 10/2021 - 07/2015
4	Messenger RNA (mRNA)IBA 01/2019 - 07/2007
4	HomocysteineIBA 12/2016 - 06/2013
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2002
3	ApolipoproteinsIBA 01/2019 - 01/2018
3	Cell-Free Nucleic AcidsIBA 04/2017 - 10/2015
3	Antipsychotic Agents (Antipsychotics)IBA 03/2017 - 09/2014
3	Nonsense Codon (Nonsense Mutation)IBA 01/2017 - 04/2010
3	EnzymesIBA 12/2014 - 02/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2023
2	oxidized low density lipoproteinIBA 12/2022 - 01/2018
2	ORALIT (ORS)IBA 07/2021 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 12/2010
2	Phenobarbital (Luminal)FDA Link 11/2019 - 07/2015
2	Apolipoproteins E (ApoE)IBA 01/2019 - 10/2018
2	Toll-Like Receptor 9IBA 01/2019 - 01/2016
2	C-Reactive ProteinIBA 02/2018 - 01/2016
2	Protein Isoforms (Isoforms)IBA 01/2018 - 03/2016
2	NucleotidesIBA 01/2017 - 01/2015
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2016 - 09/2014
2	OligonucleotidesIBA 01/2016 - 06/2012
2	Hormones (Hormone)IBA 07/2015 - 06/2015
2	Connective Tissue Growth FactorIBA 07/2014 - 08/2007
2	Decitabine FDA Link 07/2012 - 11/2005
2	Methyl-CpG-Binding Protein 2IBA 06/2012 - 01/2012
2	MethyltransferasesIBA 10/2011 - 07/2009
2	ErbB Receptors (EGF Receptor)IBA 02/2011 - 09/2005
2	Formaldehyde (Formol)FDA Link 01/2009 - 06/2007
2	ParaffinIBA 01/2009 - 06/2007
2	Small Interfering RNA (siRNA)IBA 09/2008 - 07/2007
2	LDL Receptors (LDL Receptor)IBA 10/2006 - 06/2004
2	Etoposide (VP 16)FDA LinkGeneric 01/2006 - 02/2004
1	Vitamin D FDA LinkGeneric 10/2023
1	25-hydroxyvitamin DIBA 10/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	C-PeptideIBA 01/2023
1	Cholinergic ReceptorsIBA 01/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	LDL CholesterolIBA 12/2022
1	HDL CholesterolIBA 12/2022
1	Triglycerides (Triacylglycerol)IBA 12/2022
1	CholesterolIBA 12/2022
1	Transferrin (beta 2 Transferrin)IBA 11/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	DisintegrinsIBA 01/2021

Therapy/Procedure

12	Therapeutics 01/2023 - 09/2005
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2009
4	Aftercare (After-Treatment) 04/2017 - 01/2006
2	Transplantation 10/2018 - 01/2013